buskirktodd
Mayo Clinic Center for Sleep Medicine
Education of health care professionals in advances in sleep medicine.
Author
buskirktodd
Category
Podcast website
Latest episode
Jul 8, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
The Z-Drugs: Truths and Myths for the Clinician 20.06.2024 17:44
The Z drugs are the most commonly prescribed hypnotics but are widely misunderstood. In this podcast, Dr. Bhanu Kolla discusses truth and myths for the clinician prescribing these drugs.
Restless legs: What Therapies does the Future Hold? 06.06.2024 12:28
All of us who treat restless legs realize that current therapies are far from perfect. In this podcast, Dr. Michael Silber discusses possible future approaches, some already starting to be available.
Restless Legs: The Use of Opioids 23.05.2024 16:43
Many physicians are reluctant to prescribe even low-dose opioids for chronic problems such as refractory restless legs. But opioid therapy can be life transforming for the correct patient. In this podcast, Dr. Michael Silber discusses the appropriate use of opioids for patients with restless legs refractory to other medications.
Restless Legs: How to help the Augmented Patient 09.05.2024 17:40
Patients are still presenting to sleep specialists on high doses of dopamine agonists with intense augmentation and profound insomnia. In this podcast, Dr. Michael Silber discusses how to manage patients with this distressing problem.
Restless Legs Management: Where does Iron fit in? 22.04.2024 14:32
How do we define low iron stores in restless legs? In this podcast, Dr. Michael Silber discusses diagnosis of iron deficiency and how oral and intravenous iron should be administered in restless legs syndrome.
Restless Legs: What has happened to Dopamine Agonists? 01.04.2024 18:36
The last few years have shown a major change in first-line management of restless legs. In this podcast, Dr. Michael Silber discusses why gabapentinoids are now first-line therapy rather than dopamine agonists, how they are used, and whether there is any role still for the dopaminergic drugs.
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.